Clinical Trial Update: Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies [Phase 4]

View source ↗

Summary

Phase 4 trial update for brodalumab in moderate-to-severe plaque psoriasis patients who failed IL-17A therapies; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• brodalumab (brodalumab)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2019-07-09